CVS Pharmacy vs Pfizer
Side-by-side comparison of AI visibility scores, market position, and capabilities
Largest US pharmacy chain with ~9,000 locations; expanding pharmacy-only format in 2026; parent CVS Health also operates Aetna (health insurance) and Caremark (PBM), creating a vertically integrated healthcare mega-platform from pharmacy to insura...
About
CVS Pharmacy is the largest pharmacy chain in the United States, operating approximately 9,000 retail pharmacy locations nationwide. Founded in 1963 and headquartered in Woonsocket, Rhode Island, CVS has grown from a regional drugstore chain into a healthcare mega-platform through decades of acquisitions and vertical integration. The retail pharmacy business — dispensing prescriptions, selling health and wellness products, and providing immunizations and clinical services — is the customer-facing foundation of a much larger healthcare enterprise that includes pharmacy benefit management and health insurance.\n\nCVS Pharmacy is the consumer brand within the broader CVS Health corporation, which also operates Caremark (one of the largest pharmacy benefit managers in the US, processing hundreds of millions of prescriptions annually) and Aetna (a major health insurer with tens of millions of members). This integration of retail pharmacy, PBM, and health insurance makes CVS Health one of the most vertically integrated healthcare companies in the world, with levers spanning drug dispensing, formulary management, and member health management across the full care continuum. CVS has also expanded into primary care through its MinuteClinics and the acquisition of Oak Street Health.\n\nIn 2026, CVS Pharmacy is actively expanding its pharmacy-only format — smaller footprint locations focused exclusively on prescription fulfillment and clinical pharmacy services, rather than the traditional front-end retail merchandise mix. This format evolution reflects a strategic pivot toward healthcare services as retail foot traffic shifts to e-commerce. CVS Health reported approximately $372B in total revenue, reflecting its scale across all business segments. The company faces ongoing margin pressure from drug pricing dynamics and PBM reform discussions, but its integrated model and massive national footprint make it a structurally important player in US healthcare delivery.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
About
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.